Delcath Systems, Inc. (DCTH) Covered Calls

Delcath Systems, Inc. covered calls Delcath Systems, Inc. is a development stage company focusing on the development of the Delcath PHP System, an innovative drug delivery system designed to treat cancers of the liver.

You can sell covered calls on Delcath Systems, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for DCTH (prices last updated Fri 4:16 PM ET):

Delcath Systems, Inc. (DCTH) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
14.31 +0.64 13.80 14.47 573K - 0.4
Covered Calls For Delcath Systems, Inc. (DCTH)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Feb 21 15 0.75 13.72 5.5% 55.8%
Mar 21 15 1.10 13.37 8.2% 46.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Delcath Systems, Inc. is a pharmaceutical and medical device company, which is focused on oncology and liver cancer therapy. Its proprietary drug and device combination product, Delcath Hepatic Delivery System is designed to administer high dose chemotherapy and other therapeutic agents to the liver, while controlling the systemic exposure of those agents. The company also initiated plans to investigate the Melblez kit for primary liver cancer; and focuses on the treatment of primary and metastatic liver cancers. Its proprietary product also delivers and filters melphalan hydrochloride under the trade name Delcath Hepatic CHEMOSAT Delivery System. Delcath Systems was founded on August 5, 1988 and is headquartered in New York, NY.